Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03131219
Brief Title: Study of Ravulizumab in Children and Adolescents With Atypical Hemolytic Uremic Syndrome (aHUS)

First Submitted : April 24, 2017
First Submitted that Met QC Criteria : April 24, 2017
First Posted : April 27, 2017

Results First Submitted : July 27, 2020
Results First Submitted that Met QC Criteria : August 28, 2020
Results First Posted : September 16, 2020

Last Update Submitted that Met QC Criteria : August 28, 2020
Last Update Posted : September 16, 2020